Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding shareholder value over time. See why CTKB is a Buy.
According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the global commercial release of new configurations of cell analyzers featuring breakthrough spectral ...
PALO ALTO, CALIFORNIA / ACCESS Newswire / December 3, 2025 / Bioz, Inc., the world's leading AI-powered platform for scientific research and evidence-based product recommendations, is proud to ...
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its ...
Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...
Jefferies London Healthcare Conference 2025 November 18, 2025 6:00 AM ESTCompany ParticipantsRainer Blair - President, CEO ...
Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market - A Global and Regional Analysis: Focus on Offering, Application, Methods, End User, and Regional Analysis - Analysis and Forecast, ...
Flow cytometry is a technology for assaying labelled cells suspended in fluid and passed through a detector. The labels are usually fluorescent and used for counting and sorting the cells in a signal ...
Molecular Instruments ® (MI), the inventor of the HCR™ imaging platform, and Standard BioTools Inc. (NASDAQ: LAB) today announced a strategic collaboration to develop next-generation Imaging Mass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback